Fundz

Exagen Inc. reported raising $6.59 Million in an initial SEC Form D filing, from an offering of $16 Million

PUBLIC · XGNFeb 01, 2019$6.6M of $16M raised

Amount Raised

$6.59 Million

$6.59 Million sold, per SEC Form D (first sale Feb 1, 2019)

Round Type

Venture

VistaBiotechnology

Quick answer

Exagen raised $6.59 Million in a funding round, dated February 1, 2019. Exagen is based in Vista, California, United States.

How much did Exagen raise?
Exagen raised $6.59 Million in a funding round on February 1, 2019.
What does Exagen do?
Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions.
Where is Exagen based and how big is it?
Exagen is based in Vista, California, United States.
Who are the decision-makers at Exagen?
Fundz holds 1 contact at Exagen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Exagen that raised within 45 days of this round, from Fundz verified event records.

  • Lantern Pharma raised $2.4M (Seed) on March 18, 2019.
  • Ocular Therapeutix raised $38M on March 18, 2019.
  • RNADerm Therapeutics, Inc. raised $750K (Seed) on March 15, 2019.
  • KDx Diagnostics, Inc. raised $300K (Seed) on March 15, 2019.
  • Annovis Bio raised $530K (Seed) on March 15, 2019.
  • Ovation raised $5.9M on March 15, 2019.

Who to call at Exagen, and when

A new round usually means Exagen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Exagen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Exagen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Exagen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Exagen

Location

Vista, California, United States

About

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s disease earlier and with greater accuracy. Exagen’s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Exagen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts80 people are listed at Exagen. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Exagen's next move

See what Strategic adds

Exagen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.